Pharma Stocks
-
Penny Stocks: What Does Tonix Pharmaceuticals (NASDAQ:TNXP) Update Signal?
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
Sumitomo Pharma (TSE:4506) Reports Strong First Quarter Earnings, Is The Discount Too Deep?
Sumitomo Pharma (TSE:4506) drew investor attention after reporting first quarter 2026 earnings, with sales of ¥129,495 million, net income of…
Read More » -
What GSK (LSE:GSK) And Hikma Pharmaceuticals (LSE:HIK) Reveal About Today’s Healthcare Stocks Debate
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
Stocks to watch today: Signature Global, IndusInd Bank, pharma, railway and renewable energy stocks
Investors will track Signature Global’s project expansion, IndusInd Bank’s RBI nod, regulatory developments involving United Spirits, and business updates from…
Read More » -
Nifty Pharma Index stocks: Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potential
Synopsis For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant…
Read More » -
Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus
In early August 2026, Tarsus Pharmaceuticals reported second-quarter revenue of US$173.91 million and a net loss of US$18.55 million, while…
Read More » -
Ascentage Pharma Group International (SEHK:6855) Adds Global Dealmakers As Fair Value Debate Builds
The appointment of Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer gives Ascentage Pharma Group…
Read More » -
Santen Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here’s What Analysts Think Will Happen Next
Investors in Santen Pharmaceutical Co., Ltd. (TSE:4536) had a good week, as its shares rose 2.6% to close at JP¥1,933…
Read More » -
Structure Therapeutics (GPCR) Is Up 10.6% After Advancing Oral Obesity Drug Into Phase 3 Trial
Structure Therapeutics recently advanced its obesity portfolio by dosing the first patients in its Phase 3 ACCOMPLISH trial of oral…
Read More » -
Results: Perrigo Company plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Shareholders will be ecstatic, with their stake up 27% over the past week following Perrigo Company plc‘s (NYSE:PRGO) latest quarterly…
Read More »